AL
SPXU icon

Aspiriant LLC’s ProShares UltraPro Short S&P 500 SPXU Stock Holding History

Aspiriant LLC’s Portfolio SPXU Stock Details SPXU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-513
Closed -$122K – 315
2023
Q3 		$122K Buy
+513
New +$110K 0.01% 274

Other funds holding SPXU

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RCM
Ridgepath Capital Management Knoxville, Tennessee $201M AUM 10.5% 1-Year Est. Return
AWM
Axxcess Wealth Management Carlsbad, California $3.12B AUM 21% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
GHA
GW Henssler & Associates Kennesaw, Georgia $2.12B AUM 20.77% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Aspiriant LLC's SPXU Position: Q4 2023 in Review

Aspiriant LLC sold out of ProShares UltraPro Short S&P 500 (SPXU) in Q4 2023, closing a stake of 513 shares — an estimated $122K sold.

Aspiriant LLC first reported a position in SPXU in Q3 2023 and held it in 1 quarter. The position peaked at $122K in Q3 2023. 54 funds tracked by Wall St. Rank hold SPXU as of Q4 2023.

  • Aspiriant LLC reported no remaining ProShares UltraPro Short S&P 500 position as of Q4 2023 after selling out during the quarter.
  • Aspiriant LLC sold 513 ProShares UltraPro Short S&P 500 shares in Q4 2023, an estimated $122K.
  • Aspiriant LLC first reported a position in ProShares UltraPro Short S&P 500 in Q3 2023 and held it in 1 quarter.
  • Aspiriant LLC's ProShares UltraPro Short S&P 500 position peaked at $122K in Q3 2023.
  • 54 funds tracked by Wall St. Rank held ProShares UltraPro Short S&P 500 as of Q4 2023.

Based on Aspiriant LLC's 13F filing for Q4 2023, filed 26 Jan 2024.